These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9771030

  • 21. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA, Ismailov ShSh, Berikova EM.
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [Abstract] [Full Text] [Related]

  • 22. [Treatment of pulmonary tuberculosis patients with primary drug resistant Mycobacterium tuberculosis].
    Protopopova NM, Bessonova GS, Cherednichenko LP.
    Probl Tuberk; 1987; (1):27-30. PubMed ID: 3104897
    [No Abstract] [Full Text] [Related]

  • 23. [Drug resistance in Mycobacteria tuberculosis in the Barents region of Russia and Norway].
    Mar'iandyshev AO, Tungusova OS, Kaugan D, Sandven P.
    Probl Tuberk; 2002; (2):41-3. PubMed ID: 11899806
    [Abstract] [Full Text] [Related]

  • 24. Can studies of the early bactericidal activity of rifapentine tell us how to prevent acquired rifamycin-resistant relapse?
    Wallis RS.
    Am J Respir Crit Care Med; 2005 Jul 01; 172(1):4-5. PubMed ID: 15980108
    [No Abstract] [Full Text] [Related]

  • 25. [Efficacy of chemotherapy for tuberculosis in patients who isolate drug-resistant strains of M. tuberculosis with different genotypes].
    Vasil'eva IA, Andreevskaia SN, Smirnova TG, Chernousova LI, Chukanov VI.
    Probl Tuberk Bolezn Legk; 2004 Jul 01; (8):25-8. PubMed ID: 15478554
    [Abstract] [Full Text] [Related]

  • 26. [Estimation of the possibilities of using unified chemotherapy regimens in new cases of pulmonary tuberculosis in old-age children and adolescents].
    Gubkina MF, Ershova NG.
    Probl Tuberk Bolezn Legk; 2009 Jul 01; (1):33-6. PubMed ID: 19256010
    [Abstract] [Full Text] [Related]

  • 27. Trench warfare in a battle with TB.
    Marshall E.
    Science; 2008 Jul 18; 321(5887):362-4. PubMed ID: 18635790
    [No Abstract] [Full Text] [Related]

  • 28. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK, Kim JH, Kang H, Cho JS, Smego RA.
    Int J Infect Dis; 2009 Mar 18; 13(2):170-5. PubMed ID: 18768342
    [Abstract] [Full Text] [Related]

  • 29. [Approaches to combined therapy of pulmonary tuberculosis in adolescents excreting drug-resistant Mycobacterium tuberculosis].
    Firsova VA, Rusakova LI, Grigor'eva ZP, Ryzhova AP, Iatskova TV, Poluéktova FG.
    Probl Tuberk; 2001 Mar 18; (1):28-30. PubMed ID: 11337776
    [Abstract] [Full Text] [Related]

  • 30. [Treatment of non-tuberculous pulmonary mycobacteriosis].
    Sakatani M, Nakajima Y.
    Kekkaku; 2006 Jan 18; 81(1):35-50. PubMed ID: 16479999
    [Abstract] [Full Text] [Related]

  • 31. [Maxaquin in the combined treatment of tuberculosis].
    Sokolova GB, Mozhokina GN, Kunichan AD, Elistratova NA, Perel'man MI.
    Probl Tuberk; 2000 Jan 18; (5):35-9. PubMed ID: 11077850
    [Abstract] [Full Text] [Related]

  • 32. [Long-term results of treatment for drug-resistant pulmonary tuberculosis in socially adapted patients].
    Khodashova ML, Iuditskiĭ MV, Semenova OV.
    Probl Tuberk Bolezn Legk; 2004 Jan 18; (3):26-8. PubMed ID: 15338896
    [Abstract] [Full Text] [Related]

  • 33. Controlled therapeutic trial on three second-line chemotherapy regimens (one of short duration) in pulmonary tuberculosis.
    Ait-Khaled N, Benadjila H, Loucif MS, Mounedji A, Chaulet P.
    Bull Int Union Tuberc; 1976 Jan 18; 51(1):95-102. PubMed ID: 1030318
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Toward a modern treatment of pulmonary tuberculosis. 2. Bacteriologic and pharmacologic bases and short-term treatment].
    Zegaya M.
    Tunis Med; 1984 Nov 18; 62(7):487-94. PubMed ID: 6442475
    [No Abstract] [Full Text] [Related]

  • 36. [Impact of drug resistance of the causative agent on the outcomes of treatment for pulmonary tuberculosis in the Arkhangelsk Region].
    Tungusova OS, Nizovtseva NI, Toichkina TV, Mar'iandyshev AO, Kaugan DA, Sandven P, Bjune G.
    Probl Tuberk Bolezn Legk; 2005 Nov 18; (9):38-43; discussion 43. PubMed ID: 16279517
    [Abstract] [Full Text] [Related]

  • 37. Treatment of tuberculosis.
    Iseman MD, Goble M.
    Adv Intern Med; 1988 Nov 18; 33():253-65. PubMed ID: 3125723
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].
    Khudushina TA, Voloshina EP, Adamovich NV, Maslakova MG, Terekhova ND.
    Probl Tuberk Bolezn Legk; 2005 Nov 18; (12):37-9. PubMed ID: 16496762
    [Abstract] [Full Text] [Related]

  • 40. Drug resistance of Mycobacterium tuberculosis strains isolated from patients with pulmonary tuberculosis in Archangels, Russia.
    Toungoussova S, Caugant DA, Sandven P, Mariandyshev AO, Bjune G.
    Int J Tuberc Lung Dis; 2002 May 18; 6(5):406-14. PubMed ID: 12019916
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.